酵母来源β-葡聚醣市场规模、份额和成长分析（按来源、类别、应用和地区划分）－产业预测（2026-2033）

预计到 2024 年，全球酵母β-聚葡萄糖市场规模将达到 2.183 亿美元，到 2025 年将达到 2.3686 亿美元，到 2033 年将达到 4.5491 亿美元，预测期（2026-2033 年）的复合年增长率为 8.5%。

酵母β-聚葡萄糖市场正经历着蓬勃发展，这主要得益于其作为酵母细胞壁中天然多醣的特性。这种成分在食品饮料、营养补充品、药品和个人保健产品等多个应用领域的需求不断增长，满足了追求有效健康解决方案的健康意识消费者的需求。增强免疫力、降低胆固醇和改善肠道健康等关键益处进一步推动了市场需求。消费者对天然机能性食品的偏好日益增长，以及纯素和植物性饮食趋势的兴起，都推动了市场持续成长。然而，高昂的生产成本和有限的原材料供应等挑战可能会阻碍市场成长。在製药领域，酵母β-聚葡萄糖的应用前景特别广阔，可望用于治疗包括癌症和糖尿病在内的多种疾病。

全球酵母β-聚葡萄糖市场驱动因素

酵母β-聚葡萄糖市场成长的关键因素之一是消费者对天然和有机食品日益增长的偏好。随着健康意识的增强，人们积极寻求有助于整体健康的成分。酵母β-聚葡萄糖作为一种天然成分，因其促进健康的特性而备受青睐，在市场上迅速发展。为了顺应消费者行为的这种变化，许多食品生产商正在研发和创新添加酵母β-聚葡萄糖的产品，以满足消费者对营养健康食品替代品的需求。这一趋势反映了人们对更健康生活方式的普遍追求，以及在饮食选择中寻求有效天然疗法的愿望。

限制全球酵母β-聚葡萄糖市场的因素

全球酵母β-聚葡萄糖市场面临的主要限制因素是其高额的生产成本。酵母β-聚葡萄糖生产流程复杂且成本高昂，导致整体生产成本上升。这些经济挑战可能会限制酵母β-聚葡萄糖的市场供应，从而推高价格并对市场扩张产生负面影响。因此，高生产成本和有限供应的双重压力可能会阻碍酵母β-聚葡萄糖的潜在成长和消费，给希望在各种应用领域利用其优势的相关人员带来挑战。

全球酵母β-聚葡萄糖市场趋势

全球酵母β-聚葡萄糖市场正经历显着成长，这主要得益于健康意识增强的消费者对植物性饮食的日益青睐。随着人们对植物性食品的营养和环境益处的认识不断提高，酵母β-聚葡萄糖作为一种天然成分，正受到追求更健康饮食方式人士的青睐。其增强免疫力和降低胆固醇等特性，与现代消费者的整体生活方式选择高度契合。机能性食品和膳食补充剂需求的不断增长进一步推动了这一趋势，使酵母β-聚葡萄糖成为健康和保健领域的重要参与者，从而促进了市场成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究

全球酵母源β-葡聚醣市场规模（依来源及复合年增长率划分）（2026-2033年）

• 谷物和谷类
• 菇
• 海藻
• 酵母菌

全球酵母源β-葡聚醣市场规模（按类别划分）及复合年增长率（2026-2033年）

• 不溶物
• 水溶性

全球酵母源β-葡聚醣市场规模（依应用及复合年增长率划分）（2026-2033年）

• 饮食
• 个人护理及化妆品
• 製药
• 饲料
• 其他的

全球酵母源β-葡聚醣市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Lesaffre（France）
• Kerry Group PLC（Ireland）
• Tate & Lyle PLC（UK）
• DSM-Firmenich（Switzerland）
• Merck（US）
• Kemin Industries（US）
• Alltech（US）
• Lallemand Inc.（Canada）
• Leiber GmbH（Germany）
• Associated British Foods Plc（UK）
• Angel Yeast Co., Ltd.（China）
• Ceapro Inc.（Canada）
• Specialty Biotech Co., Ltd.（US）
• Garuda International Inc.（US）
• Biotec Pharmacon（Norway）
• NutraQ AS（Norway）
• Tateyama Kagaku Group（Japan）
• AIDP Inc.（US）
• Ohly（Germany）

结论与建议

Global Yeast Beta-Glucan Market size was valued at USD 218.3 Million in 2024 and is poised to grow from USD 236.86 Million in 2025 to USD 454.91 Million by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The global yeast beta-glucan market is witnessing dynamic expansion, driven by its natural polysaccharide properties found in yeast cell walls. This ingredient is increasingly popular across diverse applications, including food and beverages, dietary supplements, pharmaceuticals, and personal care products, catering to health-conscious consumers seeking effective wellness solutions. Key benefits such as immune support, cholesterol reduction, and gut health enhancement further fuel demand. The market thrives on the rising preference for natural, functional food ingredients and aligns with growing trends like vegan and plant-based diets. However, challenges such as high production costs and limited raw material availability may hinder growth. Opportunities remain strong, particularly in the pharmaceutical sector, where yeast beta-glucan shows promise for treating various health conditions such as cancer and diabetes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Yeast Beta-Glucan market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Yeast Beta-Glucan Market Segments Analysis

Global Yeast Beta-Glucan Market is segmented by Source, Category, Application and region. Based on Source, the market is segmented into Grains & Cereal, Mushroom, Seaweed and Yeast. Based on Category, the market is segmented into Insoluble and Soluble. Based on Application, the market is segmented into Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Yeast Beta-Glucan Market

A significant factor propelling the yeast beta-glucan market is the rising consumer preference for natural and organic food options. As individuals become increasingly health-conscious, they actively seek out ingredients that contribute to their overall well-being. Yeast beta-glucan stands out as a natural component known for its health-promoting properties, garnering attention in the marketplace. This shift in consumer behavior has led many food manufacturers to innovate and create products that incorporate yeast beta-glucan, catering to the demand for nutritious and wholesome food alternatives. The trend reflects a broader commitment to healthier lifestyles and the pursuit of effective natural remedies in dietary choices.

Restraints in the Global Yeast Beta-Glucan Market

A significant limitation faced by the global yeast beta-glucan market is the elevated production expenses associated with its manufacturing. The intricate and costly processes required for producing yeast beta-glucan contribute to higher overall production costs. These financial challenges restrict the availability of yeast beta-glucan in the marketplace, resulting in increased prices that can adversely affect market expansion. Consequently, the combination of high production costs and limited accessibility may hinder the potential growth and consumption of yeast beta-glucan, posing a challenge for stakeholders seeking to capitalize on its benefits across various applications.

Market Trends of the Global Yeast Beta-Glucan Market

The Global Yeast Beta-Glucan market is experiencing a notable surge, fueled by the increasing adoption of plant-based diets among health-conscious consumers. As awareness of the nutritional and environmental benefits of plant-based eating rises, yeast beta-glucan emerges as a favored natural ingredient, appealing to those seeking healthier alternatives. Its properties, including immune support and cholesterol-lowering benefits, align well with the holistic lifestyle choices of today's consumers. This trend is further accelerated by the growing demand for functional foods and supplements, positioning yeast beta-glucan as a key player in the health and wellness sector, thereby driving market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Yeast Beta-Glucan Market Size by Source & CAGR (2026-2033)

• Market Overview
• Grains & Cereal
• Mushroom
• Seaweed
• Yeast

Global Yeast Beta-Glucan Market Size by Category & CAGR (2026-2033)

• Market Overview
• Insoluble
• Soluble

Global Yeast Beta-Glucan Market Size by Application & CAGR (2026-2033)

• Market Overview
• Food & Beverages
• Personal Care & Cosmetics
• Pharmaceuticals
• Animal Feed
• Others

Global Yeast Beta-Glucan Market Size & CAGR (2026-2033)

• North America (Source, Category, Application)
  • US
  • Canada
• Europe (Source, Category, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Source, Category, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Source, Category, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Source, Category, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Lesaffre (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tate & Lyle PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM-Firmenich (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alltech (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leiber GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Angel Yeast Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceapro Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Specialty Biotech Co., Ltd. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Garuda International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotec Pharmacon (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NutraQ AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tateyama Kagaku Group (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AIDP Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ohly (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations